194 related articles for article (PubMed ID: 34083306)
1. Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic.
Pepe P; Pepe L; Pennisi M; Fraggetta F
Anticancer Res; 2021 Jun; 41(6):3127-3130. PubMed ID: 34083306
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer.
Nossiter J; Morris M; Parry MG; Sujenthiran A; Cathcart P; van der Meulen J; Aggarwal A; Payne H; Clarke NW
BJU Int; 2022 Aug; 130(2):262-270. PubMed ID: 35080142
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic.
Fallara G; Sandin F; Styrke J; Carlsson S; Lissbrant IF; Ahlgren J; Bratt O; Lambe M; Stattin P
Scand J Urol; 2021 Jun; 55(3):184-191. PubMed ID: 33913376
[TBL] [Abstract][Full Text] [Related]
4. Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change.
Detti B; Ingrosso G; Becherini C; Lancia A; Olmetto E; Alì E; Marani S; Teriaca MA; Francolini G; Sardaro A; Aristei C; Filippi AR; Sanguineti G; Livi L
Cancer Treat Res Commun; 2021; 27():100331. PubMed ID: 33581491
[TBL] [Abstract][Full Text] [Related]
5. A Rational Approach to Managing Prostate Cancer in an Irrational Time.
Klein EA
Oncology (Williston Park); 2020 May; 34(5):163-164. PubMed ID: 32644175
[No Abstract] [Full Text] [Related]
6. Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols.
Sanchez LR; Cathelineau X; Pinto AMA; Borque-Fernando Á; Gil MJ; Yee CH; Sanchez-Salas R
Int Braz J Urol; 2020 Jul; 46(suppl.1):50-61. PubMed ID: 32549073
[TBL] [Abstract][Full Text] [Related]
7. Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.
Tandogdu Z; Collins J; Shaw G; Rohn J; Koves B; Sachdeva A; Ghazi A; Haese A; Mottrie A; Kumar A; Sivaraman A; Tewari A; Challacombe B; Rocco B; Giedelman C; Wagner C; Rogers CG; Murphy DG; Pushkar D; Ogaya-Pinies G; Porter J; Seetharam KR; Graefen M; Orvieto MA; Moschovas MC; Schatloff O; Wiklund P; Coelho R; Valero R; de Reijke TM; Ahlering T; Rogers T; van der Poel HG; Patel V; Artibani W; Wagenlehner F; Maes K; Rha KH; Nathan S; Bjerklund Johansen TE; Hawkey P; Kelly J
BJU Int; 2021 Jun; 127(6):729-741. PubMed ID: 33185026
[TBL] [Abstract][Full Text] [Related]
8. Changes in the ambulatory care of prostate cancer patients during the SARS-CoV-2 pandemic. Literature review and contribution of our group in telematic care.
García Rodríguez J; González Ruiz de León C; Sacristán González R; Méndez Ramírez S; Modrego Ulecia L; Fernández-Gómez JM
Actas Urol Esp (Engl Ed); 2021 Oct; 45(8):530-536. PubMed ID: 34531161
[TBL] [Abstract][Full Text] [Related]
9. Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans.
Klaassen Z; Stock S; Waller J; De Hoedt A; Freedland SJ
JAMA Oncol; 2022 Jun; 8(6):914-918. PubMed ID: 35389461
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 on the incidence of localized and metastatic prostate cancer among White and Black Veterans.
Lee KM; Bryant AK; Alba P; Anglin T; Robison B; Rose BS; Lynch JA
Cancer Med; 2023 Feb; 12(3):3727-3730. PubMed ID: 35984395
[TBL] [Abstract][Full Text] [Related]
11. Referral pattern for urologic malignancies before and during the COVID-19 pandemic.
Maganty A; Yu M; Anyaeche VI; Zhu T; Hay JM; Davies BJ; Yabes JG; Jacobs BL
Urol Oncol; 2021 May; 39(5):268-276. PubMed ID: 33308974
[TBL] [Abstract][Full Text] [Related]
12. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
[TBL] [Abstract][Full Text] [Related]
13. Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic.
Ginsburg KB; Curtis GL; Timar RE; George AK; Cher ML
J Urol; 2020 Oct; 204(4):720-725. PubMed ID: 32356508
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Diagnosis and Management Across Twenty Years of Clinical Practice: A Single-center Experience on 2,500 Cases.
Pepe P; Pennisi M
Anticancer Res; 2019 Mar; 39(3):1397-1401. PubMed ID: 30842174
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy.
Izzo I; Carriero C; Gardini G; Fumarola B; Chiari E; Castelli F; Quiros-Roldan E
AIDS Res Ther; 2021 Jun; 18(1):31. PubMed ID: 34088307
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
17. During the COVID-19 pandemic 20 000 prostate cancer diagnoses were missed in England.
Lemanska A; Andrews C; Fisher L; Bacon S; Mehrkar A; Inglesby P; Davy S; Goldacre B; MacKenna B; ; Walker AJ
BJU Int; 2024 May; 133(5):587-595. PubMed ID: 38414224
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.
Harke NN; Wagner C; Hermann RM; Hadaschik BA; Radtke JP; Altay-Langguth A; Aufderklamm S; Bach C; Becker-Schiebe M; Blana A; Bruns F; Buse S; Combs SE; Engels CL; Ezzibdeh E; Fiedler M; Fischer LA; Farzat M; Frismann A; Heck MM; Henkenberens C; Roesch MC; Käding C; Klautke G; Krausewitz P; Kuczyk MA; Leitsmann C; Lettmaier S; Mahjoub S; Manseck A; Medenwald D; Meyer A; Micke O; Moritz R; Ott M; Peters I; Pokupic S; Porres D; Preisser F; Reichel K; Schneider A; Schwentner C; Scobioala S; Truss M; Wegener D; Wezel F; Willborn K; Witt JH; Wittig A; Wittlinger M; Wolff HA; Zimmermanns V; Christiansen H
PLoS One; 2022; 17(6):e0269827. PubMed ID: 35700180
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.
Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3(Suppl 3):48-54. PubMed ID: 33860643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
